19 Pulmonary Embolism Clinical Trials in Sacramento, CA (2026)

Q: How do I join a clinical trial in Sacramento?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you.

Recruiting Pulmonary Embolism Studies in Sacramento

NCT04674969Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to suppo...

Sacramento, CA5,000 participantsBoston Scientific Corporation

View Study Details

NCT00231400Recruiting

Pompe Disease Registry Protocol

The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's natural history and outc...

Sacramento, CA2,000 participantsGenzyme, a Sanofi Company

View Study Details

NCT06628908Recruiting

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

Sacramento, CAPHASE31,100 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT06297291Recruiting

Global Paradise System US Post Approval Study

The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable...

Sacramento, CA1,000 participantsReCor Medical, Inc.

View Study Details

NCT07218029Recruiting

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lung...

Sacramento, CAPHASE3815 participantsMerck Sharp & Dohme LLC

View Study Details

NCT04553523Recruiting

Hydrus® Microstent New Enrollment Post-Approval Study

The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will und...

Sacramento, CANA545 participantsAlcon Research

View Study Details

NCT05267821Recruiting

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in chil...

Sacramento, CAPHASE2500 participantsNationwide Children's Hospital

View Study Details

NCT05591118Recruiting

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients wit...

Sacramento, CAPHASE3500 participantsNYU Langone Health

View Study Details

NCT07228117Recruiting

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

The purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disposable Sensor 5/Simplera Sync in people with diabet...

Sacramento, CANA400 participantsMedtronic MiniMed, Inc.

View Study Details

NCT06293469Recruiting

Accelerated Flap Coverage in Severe Lower Extremity Trauma

The goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related complications in patients with o...

Sacramento, CANA356 participantsJohns Hopkins University

View Study Details

NCT05983250Recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12)....

Sacramento, CAPHASE3230 participantsTenax Therapeutics, Inc.

View Study Details

NCT04757116Recruiting

Post-Market Study to Assess iTind Safety in Comparison to UroLift

The study objective is to evaluate the safety of the iTind device comparied to UroLift....

Sacramento, CANA206 participantsOlympus Corporation of the Americas

View Study Details

NCT07220876Recruiting

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial...

Sacramento, CANA165 participantsAvisi Technologies Inc.

View Study Details

NCT06706674Recruiting

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (AS...

Sacramento, CAPHASE3160 participantsIntra-Cellular Therapies, Inc.

View Study Details

NCT04724252Recruiting

Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children

The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients wh...

Sacramento, CAPHASE260 participantsUniversity of California, Davis

View Study Details

NCT06829264Recruiting

Testing an Evidence-Based Supported Employment Model in Autistic Young Adults

This study aims to enhance employment outcomes for young adults with autism and intellectual and developmental disabilities (IDD) through the implementation of an evidence-based supported employment m...

Sacramento, CANA60 participantsUniversity of California, Davis

View Study Details

NCT06496867Recruiting

Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis

The goal of this randomized pilot study is to assess feasibility of the trial and to collect information to inform the design of a definitive trial. Adult patients ages 60 years or older with a low-en...

Sacramento, CANA48 participantsUniversity of Southern California

View Study Details

NCT07073820Recruiting

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

The purpose of this study is to learn about the long-term safety, tolerability and effects of the study medicine (PF-07868489) for the possible treatment of PAH. PAH is a condition in which there is h...

Sacramento, CAPHASE236 participantsPfizer

View Study Details

NCT07029204Recruiting

Intralesional Cyclosporine for Alopecia Areata

Alopecia areata (AA) is a chronic autoimmune disease that causes non-scarring, focal areas of hair loss. Due to its resulting disfigurement and unpredictable course, it is recognized as a serious medi...

Sacramento, CAEARLY_PHASE112 participantsUniversity of California, Davis

View Study Details

About Pulmonary Embolism Clinical Trials in Sacramento

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 19 pulmonary embolism clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 13,193 participants. Research is being sponsored by Boston Scientific Corporation, Genzyme, a Sanofi Company, Vertex Pharmaceuticals Incorporated and 14 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Sacramento — FAQ

Are there pulmonary embolism clinical trials in Sacramento?

Yes, there are 19 pulmonary embolism clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 19 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 18, 2026 from ClinicalTrials.gov